NASDAQ · RETAIL-DRUG STORES AND PROPRIETARY STORES · SMALL CAP
Petmed Express, Inc. PETS
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$179.0M
▼ 21.1% vs FY2024
EPS · FY25
$-2.74
Dividend / sh · FY25
$0.00
Payout · FY25
-0%
ROE · FY25
-100.4%
Net margin · FY25
-32.0%
Dividend coverage
-0.6×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 179.0M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 32 cents on every revenue dollar this year.
Per share
USD -2.74
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-100.4%
Return on equity, FY2025
ROE
Operating margin-32.8%
Net margin-32.0%
Return on assets-49.8%
Each USD of equity lost 100 cents this year.
Returned to shareholders
USD 21,000.00
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 21,000.00
Net buybacks—
Share of profit-0.0%
Consecutive raises—
USD 21,000.00 in dividends went back to shareholders in a year without profit.
Growth
−10.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.2%
−10.0%
−2.7%
−1.7%
Returned to shareholders
−90.5%
−75.3%
−48.1%
−37.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.02B
Shares outstanding, FY2025
Change, 5 years+5.5%
Change, 10 years+4.6%
The share count grew 6% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 81.2M
total assets, end of FY2025
Total assetsUSD 81.2M
EquityUSD 28.9M
CashUSD 21.4M
Current ratio0.84×
Equity funds 36% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.2
0.2
0.3
0.2
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Operating income $B
−0.1
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
·
·
Income tax $B
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.1
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
−2.74
−0.30
−0.37
0.25
0.92
1.19
1.29
1.84
1.82
1.17
1.02
0.87
0.90
0.86
0.80
0.92
1.14
Dividend / sh $
0.00
0.00
0.60
1.20
1.20
1.12
1.08
1.06
0.85
0.76
0.72
0.68
0.66
1.60
0.53
0.47
0.30
Payout %
−0
−3
−167
477
130
95
84
58
47
65
71
79
74
186
66
51
26
ROE %
−100.4
−6.9
−7.2
4.4
15.1
19.5
20.3
30.1
35.7
27.0
25.9
24.0
26.8
23.6
18.7
21.5
26.8
Shares out B
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.00
0.02
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
65 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed